HOME >> BIOLOGY >> NEWS
Concerns remain about UVB damage to amphibians

CORVALLIS, Ore. The exposure of amphibians to damaging levels of ultraviolet-B radiation in sunlight is likely a significant part of global amphibian declines, researchers say, despite some recent suggestions to the contrary and a scientific controversy about what role UV-B actually plays in this crisis.

Scientists from the United States, Canada and Spain have outlined their understanding of UV-B's biological effects on amphibians in an article in Ecology, a professional journal.

In it, they respond to some recent studies that have called into question whether UV-B radiation is causing severe health problems or mortality in amphibians.

"At this point, we believe the broad body of research conclusively demonstrates that UV-B radiation can cause damage to many species of amphibians at every stage of their life cycle, from egg to adult," said Andrew Blaustein, a professor of zoology at Oregon State University and the lead author on the Ecology commentary. "It appears the damage may be even worse than we originally thought a few years ago, and it's clear that rising levels of UV-B radiation, which could be caused by erosion of Earth's protective ozone layer, can play at least a part in the amphibian declines we're seeing around the world."

Most scientists now believe, Blaustein said, that a wide range of causes explain the totality of amphibian declines, and those causes include habitat destruction, disease, parasites, introduced exotic species, environmental contaminants and other aspects of global climate change. In some cases complex chains of interlaced ecological effects can lead to amphibian disease, deformity or death.

But UV-B radiation is still high on the list of concerns, the researchers say.

"At first our field studies showed only the damage that increased levels of UV-B radiation could do to amphibian embryos, where they caused mortality in some species and not in others," Blaustein said. "But with more research we've se
'"/>

Contact: Andrew Blaustein
blaustea@science.oregonstate.edu
541-737-5356
Oregon State University
1-Jun-2004


Page: 1 2 3

Related biology news :

1. Top Experts To Address Top Food Safety Concerns At IFT Meeting
2. Blacks Environmental Concerns Equal/Exceed Whites
3. Concerns For Australian Sea Lion
4. Reclaimed Waste Water Can Augment Municipal Drinking-Water Supplies But Concerns Must Be Addressed
5. Twin Study May Ease Parents Concerns About Late Talkers, Underscores Impact Of Environment On Language Development
6. Pollution history documented through shell remains provides tool to study ecosystem change
7. Americans knowledge of genetically modified foods remains low and opinions on safety still split
8. More than 700 threatened species remain completely unprotected, new study shows
9. Scientists find fully differentiated blood cells remain able to switch identity
10. Overfishing may diminish genetic diversity even when millions of fish remain
11. Study shows fossil records remain stable in storm beds

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Concerns remain about UVB damage amphibians

(Date:7/23/2015)... 2015 Aware, Inc. (NASDAQ: AWRE ), a ... results for its second quarter ended June 30, 2015.  ... $4.5 million, a decrease of 33% compared to $6.8 million ... second quarter of 2015 was $0.3 million, or $0.01 per ... diluted share, in the same period a year ago.  ...
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... Ralco is ... Center at the Lyon County Fair to be held August 5-9 in Marshall. The ... where their meals come from and how agriculture impacts their daily lives. This unique ...
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/29/2015)... -- Sanofi, a global and diversified ... of 2015. CEO Olivier Brandicourt comments ... different businesses. Watch video interview and ... Topics covered in the interview include:  ... drivers - Diabetes - ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
Cached News: